尿液可溶性CD163在ANCA相关性血管炎中的临床应用
该研究评估了诊断级usCD163检测在ANCA相关性血管炎中的应用,建立了250 ng/mmol的 cutoff,AUC为0.978。usCD163在肾脏血管炎复发时升高,在模拟复发中保持低值,但肾病综合征范围蛋白尿会导致假阳性,用尿总蛋白归一化可纠正。
要点
- usCD163诊断活动性肾脏血管炎的cutoff为250 ng/mmol,AUC 0.978。
- usCD163在肾脏血管炎复发时升高(AUC 0.95),在非血管炎性AKI等模拟复发中保持低值。
- 肾病综合征范围蛋白尿时usCD163特异性下降,62%患者呈阳性,建议用尿总蛋白归一化。
核心结论
- usCD163在肾脏血管炎复发时升高,在模拟复发中保持低值。
- 肾病综合征中的非特异性蛋白漏出会在无肾小球巨噬细胞浸润时升高usCD163,导致假阳性,可用尿蛋白归一化纠正。
研究设计与样本
- 研究评估诊断级usCD163检测,包括405例AAV患者和121例健康对照及488例非AAV疾病对照的真实世界队列。
- 还包括84例潜在肾脏血管炎复发患者的前瞻性多中心研究。
主要发现
- 建立了诊断参考范围,活动性肾脏血管炎的cutoff为250 ng/mmol,AUC为0.978。
- 使用该cutoff,usCD163在肾脏血管炎复发中升高(AUC 0.95),但在非血管炎性AKI等模拟复发中保持低值。
- 在AAV伴肾病范围蛋白尿和原发性足细胞病患者中,usCD163特异性下降,62%的肾病综合征患者显示“阳性”usCD163。
- 在AAV伴显著蛋白尿患者中,usCD163以尿总蛋白而非肌酐归一化对诊断活动性肾脏血管炎提供最大临床效用。
关键数值与推荐
- 活动性肾脏血管炎的usCD163 cutoff为250 ng/mmol,AUC 0.978。
- 肾脏血管炎复发的usCD163 AUC为0.95。
- 肾病综合征患者中62%显示“阳性”usCD163。
临床怎么用
- usCD163可用于检测AAV患者的活动性肾脏血管炎,但需注意肾病范围蛋白尿时的假阳性。
- 在AAV伴显著蛋白尿患者中,建议用尿总蛋白归一化usCD163以提高诊断效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Up to 70% of patients with ANCA-associated vasculitis (AAV) develop GN, with 26% progressing to ESKD. Diagnostic-grade and noninvasive tools to detect active renal inflammation are needed. Urinary soluble CD163 (usCD163) is a promising biomarker of active renal vasculitis, but a diagnostic-grade assay, assessment of its utility in prospective diagnosis of renal vasculitis flares, and evaluation of its utility in proteinuric states are needed. METHODS: We assessed a diagnostic-grade usCD163 assay in (1) a real-world cohort of 405 patients with AAV and 121 healthy and 488 non-AAV disease controls; (2) a prospective multicenter study of 84 patients with potential renal vasculitis flare; (3) a longitudinal multicenter cohort of 65 patients with podocytopathy; and (4) a cohort of 29 patients with AAV (with or without proteinuria) and ten controls. RESULTS: We established a diagnostic reference range, with a cutoff of 250 ng/mmol for active renal vasculitis (area under the curve [AUC], 0.978). Using this cutoff, usCD163 was elevated in renal vasculitis flare (AUC, 0.95) but remained low in flare mimics, such as nonvasculitic AKI. usCD163's specificity declined in patients with AAV who had nephrotic-range proteinuria and in those with primary podocytopathy, with 62% of patients with nephrotic syndrome displaying a "positive" usCD163. In patients with AAV and significant proteinuria, usCD163 normalization to total urine protein rather than creatinine provided the greatest clinical utility for diagnosing active renal vasculitis. CONCLUSIONS: usCD163 is elevated in renal vasculitis flare and remains low in flare mimics. Nonspecific protein leakage in nephrotic syndrome elevates usCD163 in the absence of glomerular macrophage infiltration, resulting in false-positive results; this can be corrected with urine protein normalization.
引用
- Moran SM, Scott J, Clarkson MR, et al. The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis. J Am Soc Nephrol. 2021. PMID: 34518279. doi:10.1681/ASN.2021030382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。